JPWO2021058810A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021058810A5
JPWO2021058810A5 JP2022518971A JP2022518971A JPWO2021058810A5 JP WO2021058810 A5 JPWO2021058810 A5 JP WO2021058810A5 JP 2022518971 A JP2022518971 A JP 2022518971A JP 2022518971 A JP2022518971 A JP 2022518971A JP WO2021058810 A5 JPWO2021058810 A5 JP WO2021058810A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
trazodone
salt
pediatric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022518971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022549473A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/077017 external-priority patent/WO2021058810A1/fr
Publication of JP2022549473A publication Critical patent/JP2022549473A/ja
Publication of JPWO2021058810A5 publication Critical patent/JPWO2021058810A5/ja
Pending legal-status Critical Current

Links

JP2022518971A 2019-09-26 2020-09-25 小児用トラゾドン組成物およびその治療法 Pending JP2022549473A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962906166P 2019-09-26 2019-09-26
US62/906,166 2019-09-26
PCT/EP2020/077017 WO2021058810A1 (fr) 2019-09-26 2020-09-25 Compositions pédiatriques de trazodone et procédé de traitement associé

Publications (2)

Publication Number Publication Date
JP2022549473A JP2022549473A (ja) 2022-11-25
JPWO2021058810A5 true JPWO2021058810A5 (fr) 2023-08-01

Family

ID=72665264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022518971A Pending JP2022549473A (ja) 2019-09-26 2020-09-25 小児用トラゾドン組成物およびその治療法

Country Status (11)

Country Link
US (1) US20220331312A1 (fr)
EP (1) EP4034117A1 (fr)
JP (1) JP2022549473A (fr)
KR (1) KR20220080096A (fr)
CN (1) CN114615983A (fr)
AU (1) AU2020354534A1 (fr)
BR (1) BR112022005343A2 (fr)
CA (1) CA3153639A1 (fr)
IL (1) IL291548A (fr)
MX (1) MX2022003442A (fr)
WO (1) WO2021058810A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20071573A1 (it) 2007-07-31 2009-02-01 Acraf Composizione farmaceutica liquida stabile a base di trazodone

Similar Documents

Publication Publication Date Title
ES2626134T3 (es) Composiciones de bepotastina
EP2891494B1 (fr) Méthode d'administration d'un agent hypnotique/sédatif
US20170035716A1 (en) Method of using solabegron
KR20120092152A (ko) 타액선 기능장애의 치료
BR122014001142A2 (pt) Formulação purgativa colônica, kit, método de purgar o cólon de um paciente, e, processo de produzir a formulação purgativa colônica
EA008165B1 (ru) Композиции для лечения простуды
ITRM950763A1 (it) Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione
US12016857B2 (en) Stable liquid vigabatrin pharmaceutical composition for oral dosage
CZ295090B6 (cs) Nová kombinace loteprednolu a antihistaminik
JPH10158169A (ja) 塩化トロスピウムを含んだ医薬製剤、その調整方法および使用方法
ES2386558T3 (es) Uso de alverina en el tratamiento de afecciones cutáneas
US20080138383A1 (en) Compositions and methods for treating seizures
IT201800002413A1 (it) "composizione a base di nifedipina per uso nel trattamento delle ragadi anali e proctalgie"
EA024475B1 (ru) Композиции витамина в12 для интраназального применения
CN106511264A (zh) 一种盐酸哌甲酯口服溶液剂及其制备方法
JPWO2021058810A5 (fr)
JP2007508313A (ja) メチルフェニデート溶液および関連する投与および製造方法
KR20150095773A (ko) 건선 치료를 위한 피도티모드의 사용
US20220218627A1 (en) Intranasal administration of ketamine to cluster headache patients
JP7331149B2 (ja) 直腸および局所投与のためのゲル
US20150141473A1 (en) Pharmaceutical dosage forms of tizanidine and administration routes thereof
US11564909B2 (en) Methods and compositions for oral pilocarpine liquid
RU2814279C2 (ru) Композиция для профилактики или лечения проктологических заболеваний
US20240216359A1 (en) Treatment of neurological disorders
WO2024062443A1 (fr) Compositions pharmaceutiques